Science Explorer Back to mapMap
Discussion
Researcher · Therapeutics Clinical Research · United States

James Bradley Breitmeyer

James Bradley Breitmeyer publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction and CAR-T cell therapy research.

ORCID 0009-0000-9482-9335 OpenAlex
World rank
#731,861
of 7,710,434 ranked researchers
Rank in United States
#246,436
of 1,627,098
Works
74
Citations
2.7k
Citations per work
36.0
h-index
26
i10-index 38Top 20% in Immunology
James Bradley Breitmeyer

What does James Bradley Breitmeyer research?

James Bradley Breitmeyer's work is mostly in Medicine (37%), Immunology and Microbiology (21%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 27 works · 36.6% of their workMedicine: 27 works · 36.6% of their workOncology: 11 works · 15.4% of their workPulmonary and Respiratory Medicine: 6 works · 8.2% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 7.7% of their workGenetics: 4 works · 5.3% of their workEverything else: 24 works · 32.1% of their workLife Sciences: 23 works · 31.3% of their workImmunology and Microbiology: 15 works · 20.7% of their workImmunology: 15 works · 20.7% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 10.6% of their workMolecular Biology: 8 works · 10.6% of their workTHEIR WORKJames BradleyBreitmeyer74works
Life Sciences31%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2736.6%
  2. Everything else2432.1%
    1. Immunology and Microbiology1520.7%
    2. Biochemistry, Genetics and Molecular Biology810.6%
  1. 1Immunology21% of their works
  2. 2Oncology15% of their works
  3. 3Molecular Biology11% of their works
  4. 4Pulmonary and Respiratory Medicine8% of their works
  5. 5Radiology, Nuclear Medicine and Imaging8% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe James Bradley Breitmeyer's research?

The keywords of their largest research topics: Cancer Immunotherapy, Lymphoma, Rituximab, Autoimmunity, Fc Receptors, Therapeutic Antibodies, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Cancer Immunotherapy202 topics
  2. Lymphoma202 topics
  3. Rituximab192 topics
  4. Autoimmunity172 topics
  5. Fc Receptors141 topic
  6. Therapeutic Antibodies141 topic
  7. NK Cell Recognition131 topic
  8. Natural Killer Cells131 topic
  9. CAR T Cells121 topic
  10. Chimeric Antigen Receptor121 topic
  11. Chronic Lymphocytic Leukemia111 topic
  12. Genomic Aberrations111 topic
  13. Galectins91 topic
  14. Immune Regulation91 topic
  15. Classification81 topic
  16. Dendritic Cells81 topic
  17. Foxp381 topic
  18. Immunity81 topic
  19. Molecular Profiling81 topic
  20. TGF-ß81 topic

Where does James Bradley Breitmeyer work?

James Bradley Breitmeyer's main affiliation in the publication record is Therapeutics Clinical Research, United States.

How many publications and citations does James Bradley Breitmeyer have?

OpenAlex counts 74 works and 2,667 citations for James Bradley Breitmeyer, an h-index of 26, ranking #731,861 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about James Bradley Breitmeyer. Posts are plain text and can be reported.